Russia first to complete human trials for COVID vaccine

Russia first to complete human trials for COVID vaccine

The clinical trials of the world's first COVID-19 vaccine have been "completed" at Sechenov First Moscow State Medical University, informed the director of the Institute for Translational Medicine and Biotechnology Vadim Tarasov.

On Sunday, July 12, cyberspace was inundated with reports that Russian researchers had successfully completed trials of the "world's first coronavirus vaccine". The #vaccine is safe.

Russian Federation had allowed clinical trials of two forms of a potential COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18.

"Once the Canadian Center for Vaccinology receives the vaccine candidate it will start the clinical trial for CanSino, under the regulatory supervision of Health Canada".

The coronavirus vaccine was developed by Russia's Ministry of Defence in collaboration with Moscow's Gamalei Institute of Epidemiology and Microbiology.

Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russian Federation showed that they were developing immunity to the coronavirus. The second group of 20 volunteers were vaccinated on June 23.

Russia first to complete human trials for COVID vaccine

Even according to the World Health Organization study, both of Gamaleya Research Institute's Russian vaccines are still under Phase 1. In the second phase, "20 volunteers and three understudies" were to be included.

Phase I and Phase II trials typically test the safety of a drug before it enters Phase III trials that test its efficacy on a bigger group of volunteers.

Separately, Alexander Lukashev, the Director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, explained that the objective of this stage was to judge the vaccine's safety on humans.

"The vaccine is given twice with the same gene injected using different carriers, which allows to not just get protective immunity, but to acquire it for a longer period of time", said Gintsburg.

The Sechenov University's two groups of volunteers will be discharged Wednesday and next Monday after spending 28 days in isolation to protect them from exposure to other infections, she added.

Russian Federation is now working on eight vaccines, according to Sputnik but according to the clinical trials website, 10 vaccine candidates have been listed.